Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits

被引:7
作者
Alberto Lué [1 ,2 ]
Angel Lanas [1 ,2 ,3 ,4 ]
机构
[1] Digestive Diseases Service, University Clinic Hospital Lozano Blesa, Avenida San Juan Bosco  2. IIS Aragon, Avenida San Juan Bosco
[2] University of Zaragoza, Calle de Pedro Cerbuna
[3] CIBERehd, Av. Monforte de Lemos
关键词
Proton pump inhibitor; Small bowel; Lower gastrointestinal bleeding; Nonsteroidal anti-inflammatory drugs;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
1002 ; 100201 ;
摘要
Proton pump inhibitors(PPIs) represent a milestone in the treatment of acid-related diseases, and are the mainstay in preventing upper gastrointestinal bleeding in high-risk patients treated with nonsteroidal antiinflammatory drugs(NSAIDs) or low-dose aspirin. However, this beneficial effect does not extend to the lower gastrointestinal tract. PPIs do not prevent NSAID or aspirin-associated lower gastrointestinal bleeding(LGB). PPIs may increase both small bowel injury related to NSAIDs and low-dose aspirin treatment and the risk of LGB. Recent studies suggested that altering intestinal microbiota by PPIs may be involved in the pathogenesis of NSAID-enteropathy. An increase in LGB hospitalization rates may occur more frequently in older patients with more comorbidities and are associated with high hospital resource utilization, longer hospitalization, and increased mortality. Preventive strategies for NSAID and aspirin-associated gastrointestinal bleeding should be directed toward preventing both upper and lower gastrointestinal damage. Future research should be directed toward identifying patients at low-risk for gastrointestinal events associated with the use of NSAIDs or aspirin to avoid inappropriate PPI prescribing. Alternatively, the efficacy of new pharmacologic strategies should be evaluated in high-risk groups, with the aim of reducing the risk of both upper and lower gastrointestinal bleeding in these patients.
引用
收藏
页码:10477 / 10481
页数:5
相关论文
共 14 条
[1]   Epidemiology of Low Dose Aspirin Damage in the Lower Gastrointestinal Tract [J].
Sostres, Carlos ;
Lanas, Angel .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (35) :5094-5100
[2]  
Ángel Lanas,Patricia Carrera-Lasfuentes,Yolanda Arguedas,Santiago García,Luis Bujanda,Xavier Calvet,Julio Ponce,Ángeles Perez-Aísa,Manuel Castro,Maria Muñoz,Carlos Sostres,Luis A. García-Rodríguez.Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants[J].Clinical Gastroenterology and Hepatology,2015
[3]  
Lishou Xiong,Xinxin Huang,Li Li,Xiuyan Yang,Liuqin Liang,Zhongping Zhan,Yujin Ye,Minhu Chen.Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: A prospective randomized study[J].Digestive and Liver Disease,2015
[4]  
Hiroki Endo,Eiji Sakai,Leo Taniguchi,Takaomi Kessoku,Yasuhiko Komiya,Akiko Ezuka,Harunobu Kawamura,Masataka Taguri,Takuma Higurashi,Hidenori Ohkubo,Eiji Yamada,Hirokazu Takahashi,Masahiko Inamori,Shin Maeda,Takashi Sakaguchi,Yasuo Hata,Hajime Nagase,Atsushi Nakajima.Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry[J].Gastrointestinal Endoscopy,2014
[5]   A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury [J].
Kurokawa, Sei ;
Katsuki, Shinichi ;
Fujita, Tomoki ;
Saitoh, Yusuke ;
Ohta, Hidetoshi ;
Nishikawa, Kouji ;
Sato, Yasushi ;
Sato, Yasuhiro ;
Ohira, Koji ;
Yamada, Masataka ;
Kato, Mototsugu .
JOURNAL OF GASTROENTEROLOGY, 2014, 49 (02) :239-244
[6]  
Yoshihiro Isomura,Yutaka Yamaji,Atsuo Yamada,Yoshitaka Watanabe,Hirobumi Suzuki,Yuka Kobayashi,Shuntaro Yoshida,Hirotsugu Watabe,Yoshihiro Hirata,Haruhiko Yoshida,Kazuhiko Koike.Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs[J].Gastrointestinal Endoscopy,2014
[7]   The aspirin cardiovascular/gastrointestinal risk calculator - a tool to aid clinicians in practice [J].
Lanas, A. ;
Polo-Tomas, M. ;
Casado-Arroyo, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) :738-748
[8]   Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis [J].
Wallace, John L. ;
Syer, Stephanie ;
Denou, Emmanuel ;
de Palma, Giada ;
Vong, Linda ;
McKnight, Webb ;
Jury, Jennifer ;
Bolla, Manlio ;
Bercik, Premysl ;
Collins, Stephen M. ;
Verdu, Elena ;
Ongini, Ennio .
GASTROENTEROLOGY, 2011, 141 (04) :1314-U759
[9]  
M.Montalto,A.Gallo,V.Curigliano,F.D’Onofrio,L.Santoro,M.Covino,S.Dalvai,A.Gasbarrini,G.Gasbarrini.Clinical trial: the effects of a probiotic mixture on non‐steroidal anti‐inflammatory drug enteropathy – a randomized, double‐blind, cross‐over, placebo‐controlled study[J].Alimentary Pharmacology & Therapeutics,2010(2)
[10]  
Koji Takeuchi,Akiko Tanaka,Shinichi Kato,Kikuko Amagase,Hiroshi Satoh.Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage[J].Clinica Chimica Acta,2010(7)